Skip to content
Screener

Context Therapeutics Inc. CNTX Q3 2025 earnings

Reported November 5, 2025 · Before market open

EPS-$0.10Miss by $0.01
EPS estimate-$0.09

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.09

FAQ

When did Context Therapeutics Inc. report Q3 2025 earnings?
Context Therapeutics Inc. (CNTX) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Context Therapeutics Inc.'s Q3 2025 revenue and EPS?
Context Therapeutics Inc. reported eps of $-0.10 for Q3 2025.
Did Context Therapeutics Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.09 by $0.01.
How did Context Therapeutics Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 54.5% from $-0.22.
Where can I find Context Therapeutics Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-049604) and the 10-Q periodic report (0001628280-25-049533) directly on SEC EDGAR. The filing index links above go to sec.gov.